Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 75

1.

Multitargeting and antimetastatic potentials of silibinin in human HepG-2 and PLC/PRF/5 hepatoma cells.

Ghasemi R, Ghaffari SH, Momeny M, Pirouzpanah S, Yousefi M, Malehmir M, Alimoghaddam K, Ghavamzadeh A.

Nutr Cancer. 2013;65(4):590-9. doi: 10.1080/01635581.2013.770043.

PMID:
23659451
2.

Silibinin efficacy against human hepatocellular carcinoma.

Varghese L, Agarwal C, Tyagi A, Singh RP, Agarwal R.

Clin Cancer Res. 2005 Dec 1;11(23):8441-8.

3.

Effects of silibinin on cell growth and invasive properties of a human hepatocellular carcinoma cell line, HepG-2, through inhibition of extracellular signal-regulated kinase 1/2 phosphorylation.

Momeny M, Khorramizadeh MR, Ghaffari SH, Yousefi M, Yekaninejad MS, Esmaeili R, Jahanshiri Z, Nooridaloii MR.

Eur J Pharmacol. 2008 Sep 4;591(1-3):13-20. doi: 10.1016/j.ejphar.2008.06.011. Epub 2008 Jun 7.

PMID:
18599034
4.

Therapeutic efficacy of silibinin on human neuroblastoma cells: Akt and NF-κB expressions may play an important role in silibinin-induced response.

Yousefi M, Ghaffari SH, Soltani BM, Nafissi S, Momeny M, Zekri A, Behmanesh M, Alimoghaddam K, Ghavamzadeh A.

Neurochem Res. 2012 Sep;37(9):2053-63. doi: 10.1007/s11064-012-0827-9. Epub 2012 Jun 21.

PMID:
22717697
5.

Variant 1 of KIAA0101, overexpressed in hepatocellular carcinoma, prevents doxorubicin-induced apoptosis by inhibiting p53 activation.

Liu L, Chen X, Xie S, Zhang C, Qiu Z, Zhu F.

Hepatology. 2012 Nov;56(5):1760-9. doi: 10.1002/hep.25834. Epub 2012 Oct 14.

PMID:
22576474
6.

Enhanced expression of matrix metalloproteinase-9 by hepatitis B virus infection in liver cells.

Chung TW, Moon SK, Lee YC, Kim JG, Ko JH, Kim CH.

Arch Biochem Biophys. 2002 Dec 15;408(2):147-54.

PMID:
12464265
8.

Antrodia cinnamomea fruiting bodies extract suppresses the invasive potential of human liver cancer cell line PLC/PRF/5 through inhibition of nuclear factor kappaB pathway.

Hsu YL, Kuo PL, Cho CY, Ni WC, Tzeng TF, Ng LT, Kuo YH, Lin CC.

Food Chem Toxicol. 2007 Jul;45(7):1249-57. Epub 2007 Jan 17.

PMID:
17316946
9.

Differential promoter usage for insulin-like growth factor-II gene in Chinese hepatocellular carcinoma with hepatitis B virus infection.

Tang SH, Yang DH, Huang W, Zhou M, Zhou HK, Lu XH, Ye G.

Cancer Detect Prev. 2006;30(2):192-203. Epub 2006 May 12.

PMID:
16697535
10.

p53 gene mutation and integrated hepatitis B viral DNA sequences in human liver cancer cell lines.

Hsu IC, Tokiwa T, Bennett W, Metcalf RA, Welsh JA, Sun T, Harris CC.

Carcinogenesis. 1993 May;14(5):987-92.

PMID:
8389256
11.

Association of mortalin (HSPA9) with liver cancer metastasis and prediction for early tumor recurrence.

Yi X, Luk JM, Lee NP, Peng J, Leng X, Guan XY, Lau GK, Beretta L, Fan ST.

Mol Cell Proteomics. 2008 Feb;7(2):315-25. Epub 2007 Oct 14.

12.

The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.

Matsuzaki Y, Sato M, Saito Y, Karube M, Doy M, Shoda J, Abei M, Tanaka N, Hadama T, Kinoshita M.

J Exp Clin Cancer Res. 1999 Sep;18(3):379-89. Erratum in: J Exp Clin Cancer Res 2000 Mar;19(1):125.

PMID:
10606185
13.

Hepatitis B, aflatoxin B(1), and p53 codon 249 mutation in hepatocellular carcinomas from Guangxi, People's Republic of China, and a meta-analysis of existing studies.

Stern MC, Umbach DM, Yu MC, London SJ, Zhang ZQ, Taylor JA.

Cancer Epidemiol Biomarkers Prev. 2001 Jun;10(6):617-25.

14.

HBV DNA integration and HBV-transcript expression in non-B, non-C hepatocellular carcinoma in Japan.

Tamori A, Nishiguchi S, Kubo S, Narimatsu T, Habu D, Takeda T, Hirohashi K, Shiomi S.

J Med Virol. 2003 Dec;71(4):492-8.

PMID:
14556260
15.

Effects and mechanisms of silibinin on human hepatoma cell lines.

Lah JJ, Cui W, Hu KQ.

World J Gastroenterol. 2007 Oct 28;13(40):5299-305.

16.

[Study on p53 gene mutation in hepatocellular carcinoma patients in China].

Kang G, Fang Z, Volkmann M.

Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2001 Jun;15(2):163-5. Chinese.

PMID:
11436649
17.

Chemopreventive action of Lygodium flexuosum extract in human hepatoma PLC/PRF/5 and Hep 3B cells.

Wills PJ, Asha VV.

J Ethnopharmacol. 2009 Mar 18;122(2):294-303. doi: 10.1016/j.jep.2009.01.006. Epub 2009 Jan 9.

PMID:
19168119
18.

Ardipusilloside inhibits survival, invasion and metastasis of human hepatocellular carcinoma cells.

Lou L, Ye W, Chen Y, Wu S, Jin L, He J, Tao X, Zhu J, Chen X, Deng A, Wang J.

Phytomedicine. 2012 May 15;19(7):603-8. doi: 10.1016/j.phymed.2012.01.003. Epub 2012 Feb 18.

PMID:
22349030
19.

Liver-intestine cadherin predicts microvascular invasion and poor prognosis of hepatitis B virus-positive hepatocellular carcinoma.

Ding ZB, Shi YH, Zhou J, Shi GM, Ke AW, Qiu SJ, Wang XY, Dai Z, Xu Y, Fan J.

Cancer. 2009 Oct 15;115(20):4753-65. doi: 10.1002/cncr.24513.

20.

Silibinin inhibits invasive properties of human glioblastoma U87MG cells through suppression of cathepsin B and nuclear factor kappa B-mediated induction of matrix metalloproteinase 9.

Momeny M, Malehmir M, Zakidizaji M, Ghasemi R, Ghadimi H, Shokrgozar MA, Emami AH, Nafissi S, Ghavamzadeh A, Ghaffari SH.

Anticancer Drugs. 2010 Mar;21(3):252-60.

PMID:
20166242

Supplemental Content

Support Center